Akèy › Fibrilasyon atriyal › Massachusetts › Boston
Etid klinik pou Fibrilasyon atriyal nan Boston, MA
17 etid pou Fibrilasyon atriyal ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Ap rekriteFaz 3
- Tufts Medical Center, Boston
- Mass General Hospital, Boston
- Brigham and Women's Hospital, Boston
- ak 3 plis
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Ap rekriteFaz 2
- Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC), Boston
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
Ap rekriteFaz 4
- Boston VA CSP Coordinating Center, Boston
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Ap rekriteEtid obsèvasyon
- Brigham and Women's Hospital, Boston
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Ap rekriteFaz 2
- Massachusetts General Hospital - Cardiology, Boston
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Ap rekrite
- Boston University Medical Center, Boston
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Ap rekrite
- Massachusetts General Hospital, Boston
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AF
Ap rekrite
- Massachusetts General Hospital, Boston
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Ap rekriteFaz 3
- Anthos Investigative Site 9918, Boston
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Ap rekriteEtid obsèvasyon
- Brigham and Women's Hospital, Boston
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
Ap rekriteFaz 1 bonè
- Brigham and Women Hospital, Boston
Medtronic Terminate AF Study
Ap rekrite
- Massachusetts General Hospital, Boston
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Ap rekriteFaz 3
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Medical Center, Boston
- ak 1 plis
Positron Emission Tomography (PET) Imaging of Thrombosis
Ap rekriteFaz 1Volontè an sante akeyi
- Massachusetts General Hospital, Boston
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Ap rekriteEtid obsèvasyon
- The Brigham and Womens Hospital, Boston
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Ap rekrite
- Brigham and Woman's Hospital, Boston
Etid Fibrilasyon atriyal nan lòt vil
- New York City, NY21 etid
- Cleveland, OH17 etid
- Atlanta, GA16 etid
- Philadelphia, PA12 etid
- Jonesboro, AR12 etid
- Chicago, IL12 etid
- Ann Arbor, MI11 etid
- Pittsburgh, PA10 etid
- Cincinnati, OH10 etid
- Columbus, OH10 etid
- Austin, TX9 etid
- Houston, TX9 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.